514 participants
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-10-29
- Start Date:
- 2023-06-01
- Completion:
- 2023-07-12
Conditions
- Multiple Myeloma
Interventions
- DRUG